OTCMKTS:GWHP

Global WholeHealth Partners Competitors

$0.49
-0.06 (-10.88 %)
(As of 05/10/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.46
$0.59
50-Day Range
$0.52
$0.75
52-Week Range
$0.40
$14.50
Volume438,821 shs
Average Volume249,549 shs
Market Capitalization$38.34 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Global WholeHealth Partners (OTCMKTS:GWHP) Vs. OCDX, OLK, NOTV, BDSX, AKU, and LHDX

Should you be buying GWHP stock or one of its competitors? Companies in the industry of "diagnostics & research" are considered alternatives and competitors to Global WholeHealth Partners, including Ortho Clinical Diagnostics (OCDX), Olink Holding AB (publ) (OLK), Inotiv (NOTV), Biodesix (BDSX), Akumin (AKU), and Lucira Health (LHDX).

Global WholeHealth Partners (OTCMKTS:GWHP) and Ortho Clinical Diagnostics (NASDAQ:OCDX) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings and dividends.

Valuation & Earnings

This table compares Global WholeHealth Partners and Ortho Clinical Diagnostics' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global WholeHealth PartnersN/AN/AN/AN/AN/A
Ortho Clinical DiagnosticsN/AN/AN/AN/AN/A

Profitability

This table compares Global WholeHealth Partners and Ortho Clinical Diagnostics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global WholeHealth PartnersN/AN/AN/A
Ortho Clinical DiagnosticsN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings for Global WholeHealth Partners and Ortho Clinical Diagnostics, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global WholeHealth Partners0000N/A
Ortho Clinical Diagnostics011102.92

Ortho Clinical Diagnostics has a consensus price target of $24.5455, indicating a potential upside of 15.94%. Given Ortho Clinical Diagnostics' higher probable upside, analysts clearly believe Ortho Clinical Diagnostics is more favorable than Global WholeHealth Partners.

Summary

Ortho Clinical Diagnostics beats Global WholeHealth Partners on 2 of the 2 factors compared between the two stocks.

Global WholeHealth Partners (OTCMKTS:GWHP) and Olink Holding AB (publ) (NASDAQ:OLK) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Valuation and Earnings

This table compares Global WholeHealth Partners and Olink Holding AB (publ)'s top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global WholeHealth PartnersN/AN/AN/AN/AN/A
Olink Holding AB (publ)N/AN/AN/AN/AN/A

Profitability

This table compares Global WholeHealth Partners and Olink Holding AB (publ)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global WholeHealth PartnersN/AN/AN/A
Olink Holding AB (publ)N/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Global WholeHealth Partners and Olink Holding AB (publ), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global WholeHealth Partners0000N/A
Olink Holding AB (publ)02202.50

Olink Holding AB (publ) has a consensus price target of $44.00, suggesting a potential upside of 64.61%. Given Olink Holding AB (publ)'s higher probable upside, analysts plainly believe Olink Holding AB (publ) is more favorable than Global WholeHealth Partners.

Summary

Olink Holding AB (publ) beats Global WholeHealth Partners on 2 of the 2 factors compared between the two stocks.

Global WholeHealth Partners (OTCMKTS:GWHP) and Inotiv (NASDAQ:NOTV) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Valuation and Earnings

This table compares Global WholeHealth Partners and Inotiv's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global WholeHealth PartnersN/AN/AN/AN/AN/A
InotivN/AN/AN/AN/AN/A

Profitability

This table compares Global WholeHealth Partners and Inotiv's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global WholeHealth PartnersN/AN/AN/A
InotivN/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Global WholeHealth Partners and Inotiv, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global WholeHealth Partners0000N/A
Inotiv0000N/A

Global WholeHealth Partners (OTCMKTS:GWHP) and Biodesix (NASDAQ:BDSX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Valuation and Earnings

This table compares Global WholeHealth Partners and Biodesix's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global WholeHealth PartnersN/AN/AN/AN/AN/A
BiodesixN/AN/AN/AN/AN/A

Profitability

This table compares Global WholeHealth Partners and Biodesix's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global WholeHealth PartnersN/AN/AN/A
BiodesixN/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Global WholeHealth Partners and Biodesix, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global WholeHealth Partners0000N/A
Biodesix00403.00

Biodesix has a consensus price target of $26.00, suggesting a potential upside of 73.22%. Given Biodesix's higher probable upside, analysts plainly believe Biodesix is more favorable than Global WholeHealth Partners.

Summary

Biodesix beats Global WholeHealth Partners on 2 of the 2 factors compared between the two stocks.

Global WholeHealth Partners (OTCMKTS:GWHP) and Akumin (NASDAQ:AKU) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and earnings.

Institutional & Insider Ownership

30.4% of Akumin shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Global WholeHealth Partners and Akumin's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global WholeHealth PartnersN/AN/AN/AN/AN/A
AkuminN/AN/AN/AN/AN/A

Profitability

This table compares Global WholeHealth Partners and Akumin's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global WholeHealth PartnersN/AN/AN/A
AkuminN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and target prices for Global WholeHealth Partners and Akumin, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global WholeHealth Partners0000N/A
Akumin00103.00

Summary

Akumin beats Global WholeHealth Partners on 2 of the 2 factors compared between the two stocks.

Global WholeHealth Partners (OTCMKTS:GWHP) and Lucira Health (NASDAQ:LHDX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and earnings.

Earnings & Valuation

This table compares Global WholeHealth Partners and Lucira Health's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global WholeHealth PartnersN/AN/AN/AN/AN/A
Lucira HealthN/AN/AN/AN/AN/A

Profitability

This table compares Global WholeHealth Partners and Lucira Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global WholeHealth PartnersN/AN/AN/A
Lucira HealthN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and target prices for Global WholeHealth Partners and Lucira Health, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global WholeHealth Partners0000N/A
Lucira Health11102.00

Lucira Health has a consensus target price of $9.00, suggesting a potential upside of 97.37%. Given Lucira Health's higher probable upside, analysts plainly believe Lucira Health is more favorable than Global WholeHealth Partners.

Summary

Lucira Health beats Global WholeHealth Partners on 2 of the 2 factors compared between the two stocks.


Global WholeHealth Partners Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Ortho Clinical Diagnostics logo
OCDX
Ortho Clinical Diagnostics
1.7$21.17-2.5%$4.71 billionN/A0.00
OLK
Olink Holding AB (publ)
1.2$26.73-13.3%$3.18 billionN/A0.00
NOTV
Inotiv
0.3$28.71-2.8%$408.43 millionN/A0.00Analyst Revision
Gap Up
Biodesix logo
BDSX
Biodesix
1.6$15.01-5.1%$403.14 millionN/A0.00
Akumin logo
AKU
Akumin
0.6$3.06-2.9%$217.73 millionN/A0.00
Lucira Health logo
LHDX
Lucira Health
1.0$4.56-8.1%$175.72 millionN/A0.00Upcoming Earnings
Analyst Report
Relay Medical logo
RYMDF
Relay Medical
0.0$0.25-0.0%$37.18 millionN/A0.00Gap Down
Epigenomics logo
EPGNY
Epigenomics
0.6$7.80-0.0%$0.00N/A0.00
ETAH
Eternity Healthcare
0.6$0.00-0.0%$0.00N/A0.00
MEDD
Medical Imaging
0.4$0.01-27.1%$0.00N/A0.00News Coverage
Gap Down
Parallax Health Sciences logo
PRLX
Parallax Health Sciences
0.5$0.01-0.0%$0.00N/A0.00
Siemens Healthineers logo
SMMNY
Siemens Healthineers
0.5$28.65-3.6%$0.00N/A0.00Gap Down
WUXIF
WuXi AppTec
1.0$19.88-0.0%$0.00N/A0.00
This page was last updated on 5/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.